Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
A police officer performs puja in front of a truck carrying the first consignment of Covishield before it leaves the Serum Bio-Pharma Park of Serum Institute of India, in Pune on Tuesday - STRINGER
The government on Tuesday said that the two Covid-19 vaccines available in India are just a fourth the price of the cheapest in the world, but did not explain the criteria to be followed in deciding who gets which vaccine.
According to Health Secretary Rajesh Bhushan, the option of choosing the vaccine will not be available to the beneficiary. This is the practice in countries where more than one vaccine is available, he said.
The government has placed orders for 110-lakh doses of Covishield, the AstraZeneca-Oxford University vaccine, produced by Serum Institute of India (SII), and 55-lakh doses of Covaxin from Bharat Biotech. Covishield is priced at ₹200 and Covaxin at ₹295 a dose. However, since Bharat Biotech is providing 16.5-lakh doses free of cost to the government, the per dose cost works out to ₹206, said Bhushan, while briefing the media. The vaccines are cheaper in India as the firms are not selling them at market price.
Some of the cheapest vaccines available globally are the Russian Sputnik-V and that being developed by Johnson & Johnson, which are priced at $10 (approx. Rs.740) each a dose.
The government has so far lifted 54,72,000 doses of the vaccines and the procurement would end by January 14, Bhushan said.
Talking to media in Pune, SII CEO Adar Poonawalla said the special price of ₹200 is only for the government. This price would be applicable for the agreed supply of 5.6 crore doses, he said, hours after trucks carrying 56.5-lakh doses of Covishield rolled out of the firm’s Pune facility.
When the vaccine hits the private market, it is expected to cost around ₹1,000 a dose, Poonawalla said.
From the four general medicine supply depots in Chennai, Karnal, Kolkata and Mumbai, the vaccines will be transported to regional vaccine centres, under the control of the respective State governments.
All States have at least one regional vaccine centre. However, Uttar Pradesh has nine centres, Gujarat and Madhya Pradesh four each, Kerala three, and Karnataka and Rajasthantwo each, Bhushan said.
Vinod Paul, Member (Health), NITI Aayog, said both vaccines are safe, immunogenic and devoid of any side-effects.
“They are in fact safer than many other vaccines used for routine immunisation in the country,” Paul added.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
Only half the Sensex stocks have bettered the index’s return in the last 10,000-point journey
High valuation and stiff competition from larger players are a dampener
Investors with a short-term perspective can buy The New India Assurance Company (NIACL) stock at current ...
₹1490 • HDFC Bank S1S2R1R2COMMENT 1475146015051520 Fresh short positions are recommended with a stiff ...
What makes the new crop of young Indian cricketers such game-changing winners? Over and above their talent, ...
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
‘You ready to go to work?’ Joe Biden had asked Kamala Harris before naming her as his running mate. ‘Oh my ...
Writer Narendra’s latest book, rich with vignettes from Bastar and his native village in Uttar Pradesh, ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...